We are live on ! Find out more
GP

Girard Partners Portfolio holdings

AUM $1.06B
1-Year Est. Return 17.26%
This Fund
S&P 500
This Quarter Est. Return
+10.99%
1 Year Est. Return
+17.26%
3 Year Est. Return
+25.75%
5 Year Est. Return
+90.99%
10 Year Est. Return
+213.34%
AUM
$920M
AUM Growth
+$128M
Cap. Flow
+$48.7M
Cap. Flow %
5.29%
Top 10 Hldgs %
31.83%
Holding
266
New
14
Increased
103
Reduced
96
Closed
9

Top Sells

Rank Stock Value
1
FIS icon
Fidelity National Information Services
FIS
+$2.03M
2
LDOS icon
Leidos
LDOS
+$1.35M
3
TSLA icon
Tesla
TSLA
+$1.21M
4
LMT icon
Lockheed Martin
LMT
+$1.17M
5
LW icon
Lamb Weston
LW
+$870K

Sector Composition

Rank Sector Weight
1 Technology 21.01%
2 Financials 10.56%
3 Healthcare 10.35%
4 Consumer Discretionary 9.77%
5 Communication Services 6.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MKC icon
201
McCormick & Company Non-Voting
MKC
$13.9B
$289K 0.03%
3,000
ABMD
202
DELISTED
Abiomed Inc
ABMD
$287K 0.03%
800
GD icon
203
General Dynamics
GD
$106B
$279K 0.03%
1,340
-107
-7% -$21.6K
SLB icon
204
SLB Ltd
SLB
$74.2B
$277K 0.03%
+9,270
New +$292K
BSV icon
205
Vanguard Short-Term Bond ETF
BSV
$44.7B
$269K 0.03%
3,329
+346
+12% +$28.1K
BNY
206
Bank of New York Mellon
BNY
$106B
$264K 0.03%
4,548
O icon
207
Realty Income
O
$61.3B
$264K 0.03%
3,698
-243
-6% -$16.7K
SPTM icon
208
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$13.5B
$258K 0.03%
+4,415
New +$250K
BOND icon
209
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.42B
$254K 0.03%
2,330
-503
-18% -$55.2K
BMY icon
210
Bristol-Myers Squibb
BMY
$130B
$250K 0.03%
4,019
-184
-4% -$10.8K
DHR icon
211
Danaher
DHR
$140B
$250K 0.03%
857
-8
-0.9% -$2.2K
DFS
212
DELISTED
Discover Financial Services
DFS
$248K 0.03%
2,153
SUB icon
213
iShares Short-Term National Muni Bond ETF
SUB
$11.3B
$245K 0.03%
2,285
ESS icon
214
Essex Property Trust
ESS
$18.9B
$239K 0.03%
680
-417
-38% -$142K
VFC icon
215
VF Corp
VFC
$7.16B
$237K 0.03%
3,243
-256
-7% -$18.7K
DE icon
216
Deere & Co
DE
$173B
$230K 0.03%
672
-100
-13% -$34.8K
CL icon
217
Colgate-Palmolive
CL
$74.2B
$227K 0.02%
2,661
-629
-19% -$49.1K
SCHX icon
218
Schwab US Large- Cap ETF
SCHX
$71.3B
$217K 0.02%
+11,466
New +$212K
MU icon
219
Micron Technology
MU
$927B
$216K 0.02%
+2,321
New +$181K
PEG icon
220
Public Service Enterprise Group
PEG
$39.3B
$214K 0.02%
3,207
-300
-9% -$19K
NSC icon
221
Norfolk Southern
NSC
$76.1B
$213K 0.02%
+718
New +$200K
SCHP icon
222
Schwab US TIPS ETF
SCHP
$16.4B
$212K 0.02%
+6,742
New +$212K
IEMG icon
223
iShares Core MSCI Emerging Markets ETF
IEMG
$147B
$207K 0.02%
3,469
-1,504
-30% -$92.8K
ES icon
224
Eversource Energy
ES
$28.4B
$206K 0.02%
2,265
-352
-13% -$30.3K
YUMC icon
225
Yum China
YUMC
$15.6B
$203K 0.02%
4,083

Similar funds

Girard Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Girard Partners held 266 positions worth $920M, up 16% from $792M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Girard Partners deployed $48.7M of net new capital in Q4 2021, opening 14 new positions and adding to 103 existing holdings. Its largest new stake was Toronto Dominion Bank: 64,679 shares worth $4.96M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Fidelity National Information Services, an estimated $2.03M trimmed.

  • Girard Partners's largest Q4 2021 buy was Toronto Dominion Bank: 64,679 shares worth $4.96M.
  • Girard Partners added most to State Street SPDR Portfolio Aggregate Bond ETF in Q4 2021, an estimated $7.32M increase.
  • Girard Partners's biggest Q4 2021 reduction was Fidelity National Information Services, cutting an estimated $2.03M.
  • Girard Partners fully exited Gilead Sciences in Q4 2021, selling an estimated $296K.
  • Girard Partners's ten largest holdings make up 32% of its $920M portfolio in Q4 2021.
  • Girard Partners opened 14 new positions and closed 9 in Q4 2021.
  • Girard Partners's portfolio value rose 16% quarter-over-quarter to $920M.

Based on Girard Partners's 13F filing for Q4 2021, filed 2 Feb 2022.